
    
      This study will be proposed to every patient that correspond to eligibility criteria, such as
      presenting a severe headache (Visual Analog Scale â‰¥ 6/10) within 3 hours before arriving to
      the emergency.

      After signing the informed consent, a blood sample will be taken in order to dosage S100B
      protein of each patient, and then they will have a brain scan.

      The trial ends after the brain scan for each patient. Results of brain scans will be compared
      with results of S100B dosage.
    
  